Skip to main content

Live Werewolf Therapeutics, Inc. Common Stock Share Price Chart

O H L

Werewolf Therapeutics, Inc. Common Stock Performance Overview

Days Range
▼
$0.91Low
$0.92High

Markets Today

Previous Close$0.92
Open$0.91
Volume192,047
Day's Range$0.91 - $0.92
52W Range$0.27 - $2.15
Market Cap$45.20 M

Historical Performance

1M Returns-6.10
3M Returns+167.50
6M Returns-7.98
1Y Returns-52.32
5Y Returns-94.50
10Y ReturnsNA

Werewolf Therapeutics, Inc. Common Stock Fundamentals

Market Cap$45.20 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-1.24
EPS TTM$-0.73
Quarterly Earnings Growth YOYN/A
PB Ratio2.77
EBITDA$-59.04 M
Profit MarginN/A
Market Cap$45.20 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-1.24
EPS TTM$-0.73
Quarterly Earnings Growth YOYN/A
PB Ratio2.77
EBITDA$-59.04 M
Profit MarginN/A

Werewolf Therapeutics, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$21.00 M
Gross Profit +$0$0$0$0$0$21.00 M
Operating Income -$17.99 M-$17.54 M-$15.73 M-$9.42 M-$13.27 M$7.16 M
EBITDA -$17.57 M-$17.14 M-$15.32 M-$9.02 M-$12.87 M$9.61 M
Interest Expense -$1.26 M-$1.30 M-$1.34 M-$1.37 M-$1.37 M-$475.00 K
Depreciation $426.00 K$406.00 K$402.00 K$400.00 K$398.00 K$2.45 M
Income Before Tax -$18.09 M-$17.98 M-$16.37 M-$8.38 M-$13.53 M$3.67 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$18.09 M-$17.98 M-$16.37 M-$8.38 M-$13.53 M$3.67 M
Net Profit Margin -----17.48%

Werewolf Therapeutics, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $5.00 K$5.00 K$5.00 K$5.00 K$5.00 K$5.00 K
Reserve & Surplus -$432.68 M-$450.66 M-$467.03 M-$475.41 M-$488.94 M-$485.27 M
Non-Current Liabilities $38.26 M$35.93 M$32.41 M$8.44 M$7.30 M$0
Current Liabilities $11.67 M$15.17 M$17.60 M$36.15 M$38.52 M$7.86 M
Total Liabilities $49.93 M$51.10 M$50.01 M$44.59 M$45.82 M$7.86 M
Fixed Assets $5.90 M$5.49 M$5.09 M$4.69 M$4.29 M$1.26 M
Current Assets $94.46 M$80.44 M$68.17 M$58.59 M$48.73 M$22.89 M
Total Assets $107.24 M$92.57 M$79.63 M$69.40 M$58.02 M$24.16 M

Werewolf Therapeutics, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$18.09 M-$17.98 M-$16.37 M-$8.38 M-$13.53 M$3.67 M
Operating Cash Flow -$18.95 M-$15.16 M-$15.16 M-$11.02 M-$10.60 M$6.63 M
Investing Cash Flow $0$0$0$0$0$416.00 K
Financing Cash Flow $0$388.00 K$3.27 M$2.37 M$0-$32.41 M
Change in Cash -$18.95 M-$14.78 M-$11.88 M-$8.66 M-$10.60 M-$25.37 M

Werewolf Therapeutics, Inc. Common Stock Return Calculator

The Werewolf Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$544
Invested Amount$10,000
Est. Returns$-9,456
Invest in USA Stock Today

About Werewolf Therapeutics, Inc. Common Stock

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

FAQs

Werewolf Therapeutics, Inc. Common Stock (HOWL) share price as of October 7, 2026 is $0.91. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Werewolf Therapeutics, Inc. Common Stock (HOWL) Share by opening an international trading account with Angel One.
Purchasing Werewolf Therapeutics, Inc. Common Stock (HOWL) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Werewolf Therapeutics, Inc. Common Stock (HOWL) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Werewolf Therapeutics, Inc. Common Stock (HOWL) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Werewolf Therapeutics, Inc. Common Stock on October 7, 2026, is $45.20 M.
Werewolf Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Werewolf Therapeutics, Inc. Common Stock (HOWL) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL